LianBio Appoints Susan Silbermann to Board of Directors

4 years ago

Former Global President, Emerging Markets, brings over 30 years of expertise to LianBio Board of Directors SHANGHAI & PRINCETON, N.J.--(BUSINESS…

4 years ago

�As their popularity rises, managers need to assess the skills development needs of multigenerational teams NEW YORK--(BUSINESS WIRE)--#LnD--Multigenerational teams are…

Draganfly Signs $9 Million Exclusive Manufacturing Agreement with Digital Dream Labs

4 years ago

Los Angeles, CA., Oct. 12, 2021 (GLOBE NEWSWIRE) -- Draganfly Inc. (NASDAQ: DPRO) (CSE: DPRO) (FSE: 3U8) (�Draganfly� or the…

4 years ago

PETAH TIKVA, Israel, Oct. 12, 2021 (GLOBE NEWSWIRE) -- Gilat Satellite Networks Ltd. (NASDAQ, TASE: GILT), a worldwide leader in…

Canva Launches Video Suite to Empower Everyone to Create, Edit and Record Stunning Videos

4 years ago

68% of U.S. knowledge workers say video is becoming increasingly important in the workplace SYDNEY--(BUSINESS WIRE)--Canva, the visual communications platform,…

VIQ Solutions Announces Agreement to Acquire Assets of Court Recording and Transcription Services Company Auscript Australasia Pty Ltd

4 years ago

PHOENIX, Ariz.--(BUSINESS WIRE)--VIQ Solutions Inc. (�VIQ� or the �Company�) (TSX and Nasdaq: VQS), a global provider of secure, AI-driven, digital…

Xperi Licenses Hybrid Bonding Technology to Yangtze Memory Technologies Co., Ltd. (YMTC)

4 years ago

Direct Bond Interconnect (DBI�) hybrid bonding portfolio licensed to YMTC for its 3D NAND memory products SAN JOSE, Calif.--(BUSINESS WIRE)--Xperi…

4 years ago

BOTHELL, Wash. & TOKYO--(BUSINESS WIRE)--Seagen Inc. (Nasdaq:SGEN) and Astellas Pharma Inc. (TSE:4503, President and CEO: Kenji Yasukawa, Ph.D., �Astellas�) today…

4 years ago

- Phase 3b dosing of ARCT-154 initiated; study designed to enroll approximately 20,000 participants - Initiation of Phase 3b study…

Aerie Pharmaceuticals Announces Positive Phase 3 Topline Results for Netarsudil Ophthalmic Solution 0.02% Clinical Trial in Japan

4 years ago

Netarsudil Ophthalmic Solution 0.02% Once Daily Demonstrated Superiority to Ripasudil 0.4% Twice Daily DURHAM, N.C.--(BUSINESS WIRE)--Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an…

Show more Posts
Show previous Posts